SEOUL, May 16 (Korea Bizwire) — Celltrion Inc. will invest 40 trillion won (US$33.7 billion) and create 110,000 jobs by 2030 as the South Korean biosimilar firm moves to take a leap forward as a global player, the company’s chairman said Thursday. The company’s business roadmap centers on cooperating with local governments to make the [...]
SEOUL, Apr. 27 (Korea Bizwire) — South Korea’s pharmaceutical giant Celltrion has become a strong competitor to European and U.S. drugs with its biosimilars, indicated by changes in sales, industry officials said Friday. Multinational drugmaker Roche logged a 44 percent fall in sales of Mabthera, an antibody used to treat rheumatoid arthritis, lymphoma and some [...]
SEOUL, March 28 (Korea Bizwire) — An affiliate of South Korean biopharmaceutical firm Celltrion Inc. said Wednesday that the market share of the biosimilar drug Remsima came to 52 percent in Europe during the fourth quarter of last year. The market share of Remsima surpassed that of its original drug, Remicade, by Janssen Biotech, Inc., [...]
SEOUL, March 23 (Korea Bizwire) – The head of South Korean biopharmaceutical firm Celltrion Inc. said Friday that the company is considering building a plant in Asia in a move to boost production capacity amid rising sales. “I will prioritize a country where Celltrion can have 100 percent stake in the plant to prevent technology [...]
SEOUL, Feb. 21 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc.’s biosimilar drug Truxima will reach the Colombian market, the company’s affiliate said Wednesday. Global drug firm Mundi Pharma Inc. won exclusive rights to distribute and market the copy of Roche’s blockbuster medicine, also known as MabThera, in the South American country, Celltrion Healthcare [...]
SEOUL, Jan. 22 (Korea Bizwire) — The amount of stock sales through block deals on South Korean bourses increased sharply in 2017 from a year earlier, the Korea Exchange (KRX) said Monday. The amount surged to 55.9 trillion won (US$52.3 billion) on the KOSPI main bourse last year, up 37 percent from the previous year. [...]
SEOUL, Jan. 8 (Korea Bizwire) – Drugmaker Celltrion Inc.’s stock has made significant gains in recent days, surpassing Hyundai Motor Co. in terms of market value, data showed Monday. Celltrion shares jumped 55.12 percent over the past 7 trading sessions to 302,500 won (US$283.29) on Monday closing, pushing the company’s capitalization to a record 37.1 trillion won. Hyundai Motor’s market capitalization stood at 33.2 trillion won as of Monday closing. Celltrion’s [...]
SEOUL, Jan. 8 (Korea Bizwire) — The head of a biotech venture firm has emerged as the fourth-richest man in stock holdings in South Korea, industry data showed Sunday, amid a bio venture boom in Asia’s fourth-biggest economy. The value of stocks held by Seo Jung-jin, chairman of biopharmaceutical firm Celltrion Inc., rose to 5.39 [...]
SEOUL, Dec. 1 (Korea Bizwire) – To maintain its status as the world’s largest biopharmaceuticals manufacturing city, voices in Songdo are calling for greater cooperation between the private and public sectors. Leading biopharmaceuticals firms, among them Samsung Biologics and Celltrion, have made large investments in Songdo to build up the city’s manufacturing capabilities. By next [...]
SEOUL, Nov. 16 (Korea Bizwire) – Technology Licensing Offices at hospitals, universities and research labs had successfully inked 405 technology transfer deals with businesses as of October, the Ministry of Health and Welfare revealed on November 15. Technology Licensing Offices, commonly referred to as TLOs, are organizations set up as intermediaries that serve as the [...]